Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Scott

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Investigation|July 1, 1977
Potentiation of the function of Hageman factor fragments by high molecular weight kininogenC Y Liu, C F Scott, A Bagdasarian, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Semisynthetic arginine-15-aprotinin, an improved inhibitor for human plasma kallikreinH Tschesche, J Beckmann, A Mehlich, et al.
Transactions of the Association of American Physicians|January 1, 1979
Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogenR W Colman, C F Scott, P V Shames, et al.
The Journal of Clinical Investigation|February 1, 1986
Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIfC F Scott, R W Carrell, C B Glaser, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1990
Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strainC F Scott, S Silver, A T Profy, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Initiation of blood coagulation at artificial surfacesR W Colman, C F Scott, A H Schmaier, et al.
The Journal of Clinical Investigation|May 1, 1986
High molecular weight kininogen is an inhibitor of platelet calpainA H Schmaier, H Bradford, L D Silver, et al.
The Journal of Infectious Diseases|July 1, 1992
In vitro inhibition of a variety of human immunodeficiency virus isolates by a broadly reactive, V3-directed heteroconjugate antibodyP J Higgins, T Paradis, B J Potts, et al.
Biochemistry|February 2, 1982
High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitorsM Schapira, C F Scott, A James, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Role of high molecular weight kininogen in modulating the inactivation of human plasma kallikrein by plasma protease inhibitorsM Schapira, A James, C F Scott, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|July 1, 1977
Potentiation of the function of Hageman factor fragments by high molecular weight kininogenC Y Liu, C F Scott, A Bagdasarian, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Semisynthetic arginine-15-aprotinin, an improved inhibitor for human plasma kallikreinH Tschesche, J Beckmann, A Mehlich, et al.
Transactions of the Association of American Physicians|January 1, 1979
Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogenR W Colman, C F Scott, P V Shames, et al.
The Journal of Clinical Investigation|February 1, 1986
Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIfC F Scott, R W Carrell, C B Glaser, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1990
Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strainC F Scott, S Silver, A T Profy, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Initiation of blood coagulation at artificial surfacesR W Colman, C F Scott, A H Schmaier, et al.
The Journal of Clinical Investigation|May 1, 1986
High molecular weight kininogen is an inhibitor of platelet calpainA H Schmaier, H Bradford, L D Silver, et al.
The Journal of Infectious Diseases|July 1, 1992
In vitro inhibition of a variety of human immunodeficiency virus isolates by a broadly reactive, V3-directed heteroconjugate antibodyP J Higgins, T Paradis, B J Potts, et al.
Biochemistry|February 2, 1982
High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitorsM Schapira, C F Scott, A James, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Role of high molecular weight kininogen in modulating the inactivation of human plasma kallikrein by plasma protease inhibitorsM Schapira, A James, C F Scott, et al.
Pageof 8